Featured Research

from universities, journals, and other organizations

Researchers Identify Protein That Kills Cancer Cells

Date:
January 20, 2003
Source:
Washington University School Of Medicine
Summary:
Researchers at Washington University School of Medicine in St. Louis have found that a protein called cytidine uridine guanosine binding protein-2 (CUGBP2) can destroy several different types of cancer cells. When the team inserted the protein into cultured tumor cells, more than 70 percent self-destructed.

St. Louis, Jan. 17, 2003 – Researchers at Washington University School of Medicine in St. Louis have found that a protein called cytidine uridine guanosine binding protein-2 (CUGBP2) can destroy several different types of cancer cells. When the team inserted the protein into cultured tumor cells, more than 70 percent self-destructed.

The study appears in the Jan. 17 issue of the journal Molecular Cell. The researchers found that CUGBP2 helps regulate production of cyclooxygenase-2, (COX-2), which is better known as a key culprit in arthritis.

"The gene that produces COX-2 is turned on very early in cancer, so there has been a lot of research to see whether interfering with it might be an effective therapy," says principal investigator Shrikant Anant, Ph.D., assistant professor of medicine in the Division of Gastroenterology and research member of the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis.

In rheumatoid arthritis, COX-2 converts arachidonic acid in the body into prostaglandins. In cancer cells, COX-2 levels also rise and trigger production of prostaglandins. The prostaglandins bind to tumor cells and help turn on genes involved in the generation of new blood vessels, helping feed the cells' rapid growth.

In this study, Anant and colleagues looked at events early in the development of tumors. In any cell's life, there is a normal cycle of replication and division. First, a close copy of DNA, called RNA is made, and that RNA, in turn is translated into proteins. These proteins have to be made at precisely the right time in order for the cycle to work correctly. It is thought that tight regulation of important proteins is critical, and interfering with the strict regulation of these proteins even by a few minutes can lead to serious problems such as cancer.

That precise timing is controlled by the activity of messenger RNA (mRNA). Anant and colleagues explored the interaction of CUGBP2 with COX-2 mRNA in eight types of human cancer cells. In all eight, levels of CUGBP2 were very low.

"This suggests that an important step in the development of cancer is turning down the gene responsible for production of CUGBP2, thereby reducing CUGBP2 protein levels and allowing the cancer to flourish," Anant explains.

The researchers also found that when CUGBP2 attached to mRNA from COX-2, cancer cells no longer could make COX-2, and they died. That suggested that CUGBP2 might play a central role in tumor cell survival or death.

"CUGBP2 may be one type of master switch used by the cell to control other key proteins," says co-author Brian K. Dieckgraefe, M.D., Ph.D., assistant professor of medicine in the Division of Gastroenterology. "Proteins like COX-2 need to be tightly regulated to avoid uncontrolled growth. That may be why CUGBP2 levels were significantly lower in every single tumor we studied."

Anant, Dieckgraefe and colleagues also found that CUGBP2 was not toxic to healthy cells. Moreover, when they introduced CUGBP2 into cancer cells at the levels found in normal cells, the cancer cells died.

"When CUGBP2 is introduced, there are a number of molecular derangements that take place in the cancer cell that make it susceptible to death," Anant says. "In the future, it may be possible to use this protein as a means of killing tumor cells without harming normal cells because normal cells already produce significant amounts of the protein."

Anant already is looking at whether it is possible to use the protein in animal models of cancer to see whether it has the same effect in their tumors as it did in human cancer cells in the test tube. If these studies continue to demonstrate that it's possible to kill cancer cells by raising CUGBP2 levels, Anant believes the strategy might be ready for human testing in a few years.

Even if raising levels of CUGBP2 does not eliminate cancer, the researchers believe it may help existing therapies work better.

"Most therapeutic tools we currently use for cancer act by triggering cells to self-destruct," Dieckgraefe says. "So it's entirely possible that this might become a synergistic addition to existing therapies. By augmenting existing chemotherapy with CUGBP2, we might be able to make traditional therapies more effective."

In addition, the team says COX-2 might not be the only protein that CUGBP2 influences. Anant and Dieckgraefe say broad ranges of proteins have similar targets, so they believe CUGBP2 may have a role in regulating the production of those proteins, too.

### Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein. Molecular Cell, vol. 11:1, pp. 113-126, Jan. 17, 2003.

This research was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, and from the Foundation for Digestive Health and Nutrition of the American Gastroenterology Association.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Researchers Identify Protein That Kills Cancer Cells." ScienceDaily. ScienceDaily, 20 January 2003. <www.sciencedaily.com/releases/2003/01/030120100822.htm>.
Washington University School Of Medicine. (2003, January 20). Researchers Identify Protein That Kills Cancer Cells. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2003/01/030120100822.htm
Washington University School Of Medicine. "Researchers Identify Protein That Kills Cancer Cells." ScienceDaily. www.sciencedaily.com/releases/2003/01/030120100822.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins